ESC 365 - Conclusion - Use of single-pill combinations in patients with dyslipidemia and concomitant diseases.

EAPC Premium Access

Conclusion - Use of single-pill combinations in patients with dyslipidemia and concomitant diseases.

Session: Use of single-pill combinations in patients with dyslipidemia and concomitant diseases.

Topic: Risk Factors and Prevention

Speaker: Professor J. Morais (Leiria, PT)

Sponsored by SERVIER

Event: EuroPrevent 2019

Congress Presentation

Add to my library

About the speaker

Professor Joao Morais

Leiria Hospital Centre, Leiria (Portugal)

18 presentations

0 follower

4 more presentations in this session

Introduction - Use of single-pill combinations in patients with dyslipidemia and concomitant diseases.

Speaker: Professor D. Grobbee (Utrecht, NL)

The paradigm shift of the single-pill combination in LDL-C reduction.

Speaker: Doctor M. Farnier (Dijon, FR)

Single-pill combinations in dyslipidemia and hypertension.

Speaker: Professor C. Vlachopoulos (Athens, GR)

Discussion.

Speaker: Doctor M. Farnier (Dijon, FR) Professor D. Grobbee (Utrecht, NL) Professor J. Morais (Leiria, PT) Professor C. Vlachopoulos (Athens, GR)

Access the full session

Use of single-pill combinations in patients with dyslipidemia and concomitant diseases.

Speakers: Professor J. Morais, Professor D. Grobbee, Doctor M. Farnier, Professor C. Vlachopoulos, Doctor M. Farnier...

About the event

EuroPrevent 2019

11 April - 13 April 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources